Major Market Shift in Metered Dose Inhaler Devices Industry: Impact Of Rising COPD Prevalence On The Growth Of The Market

What Is the Forecasted Market Size and Growth Rate for the Metered Dose Inhaler Devices Market?
The market size of metered dose inhaler devices has seen robust growth in the past few years. The market is projected to swell from $15.46 billion in 2024 to $16.36 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 5.8%. The surge in growth during the historic period can be linked to rising cases of diabetes, an amplified demand for metered dose inhaler devices, an increase in supply of these devices, along with growing cases of COPD.

In the coming years, the market size for metered dose inhaler devices is predicted to experience substantial growth, reaching $20.29 billion by 2029 with an annual compound growth rate of 5.5%. Factors contributing to growth during the forecast period include a rise in chronic obstructive pulmonary diseases, an increase in asthma cases, the prevalence of infectious diseases, a surge in diabetes cases, and rise in respiratory diseases. The forecast period is also expected to witness major trends such as technological breakthroughs, innovative treatments, regulatory approvals, the introduction of new inhalers, and the utilization of internet marketing strategies.

What Factors Are Propelling the Expansion of the Metered Dose Inhaler Devices Market?
The anticipated growth of the metered dose inhaler devices market is tied to the rising incidence of chronic obstructive pulmonary disease (COPD). This progressive lung disease, defined by airflow obstruction due to long-term irritant exposure-such as tobacco smoke-causes symptoms like coughing, shortness of breath, and wheezing. The increasing occurrence of COPD is fuelled by factors like tobacco use, air pollution, aging population, and lack of timely diagnosis or treatment. Metered dose inhaler (MDI) devices aid in the management of COPD by administering medication directly to the lungs, thereby offering immediate relief and improving airflow. The National Institutes of Health, a US-based governmental agency, projected in December 2023 that the number of COPD cases would increase from 532 million in 2030 to a total of 592 million by 2050. Consequently, this escalating prevalence of chronic obstructive pulmonary diseases is propelling the growth of the metered dose inhaler devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20878&type=smp

Which Businesses Are at the Forefront of Metered Dose Inhaler Devices Market Development?
Major companies operating in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, Iconovo AB

Which Key Developments Are Influencing the Metered Dose Inhaler Devices Market?
Major players in the metered dose inhaler devices market are concentrating their efforts on the creation of advanced technological solutions, such as pressurized metered dose inhalers, to boost drug delivery effectiveness and foster better patient adherence. Pressurized metered-dose inhalers (pMDIs) are inhalation tools that use pressurized propellants to deliver an exact amount of medication in aerosol form. For example, in July 2023, the India-based pharmaceutical company, Lupin Limited, unveiled Luforbec 100/6, a pMDI for adult asthma and chronic obstructive pulmonary disease (COPD) treatment in Germany. This product, blending beclometasone (100 μg) and formoterol (6 μg), offers an efficient solution for patients who need combination therapy. Importantly, Luforbec is approximately 47% cheaper than the fixed reference price, improving its affordability. Given that asthma affects roughly 5% of Germany's adult population, this launch highlights Lupin's dedication to meet essential healthcare demands and enhance patient results in respiratory care.

How Is the Metered Dose Inhaler Devices Market Segmented?
The metered dose inhaler devices market covered in this report is segmented -

1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types
2) By Distribution Channel: Online, Offline
3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications
4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users

Subsegments:
1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices
2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices
3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report

Where Is the Metered Dose Inhaler Devices Market Growth Most Prominent?
North America was the largest region in the metered dose inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metered dose inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Metered Dose Inhaler Devices Global Market Report?

- Market Size Analysis: Analyze the metered dose inhaler devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the metered dose inhaler devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall metered dose inhaler devices market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the metered dose inhaler devices market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20878

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.